Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yamamoto, T.
Right arrow Articles by Nishioka, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, T.
Right arrow Articles by Nishioka, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 37, 1123-1125, Copyright © 1998 by British Society for Rheumatology


ORIGINAL PAPERS

Increased production of nitric oxide stimulated by interleukin-1beta in peripheral blood mononuclear cells in patients with systemic sclerosis

T Yamamoto, Y Sawada, I Katayama and K Nishioka
Department of Dermatology, Tokyo Medical and Dental University School of Medicine, Japan.

OBJECTIVE: Nitric oxide (NO) is an important mediator of immune and inflammatory responses, and has recently been suggested to play some role in the pathogenesis of autoimmune disorders. In this study, we have examined whether peripheral blood mononuclear cells (PBMC) from patients with systemic sclerosis (SSc) produce higher levels of NO spontaneously or in response to several stimulations in vitro. METHODS: PBMC were obtained from 14 patients with SSc and 15 normal volunteers. Release of NO after stimulation with lipopolysaccharide (LPS), interleukin-lbeta (IL-1beta), tumour necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) was determined by Griess reagents. RESULTS: PBMC from SSc patients exhibited a higher level of spontaneous release of NO (13.4+/-3.8 microM) than those from control subjects (8.9+/-1.6 microM), but without significance. Incubation of PBMC for 24 h with stimulants caused an increase in NO production both in normal subjects and SSc patients. Stimulation with 10 U/ml IL-1beta induced a significantly increased NO production in SSc patients (22.1+/-6.6 microM) compared with normal subjects (12.3+/-4. microM) (P < 0.05); however, in contrast, incubation with other stimulants showed no significant differences in NO production between SSc patients and normal subjects. CONCLUSION: These results suggest the abnormal regulation of NO production in PBMC of scleroderma patients in response to IL-1beta, which might contribute, in part, to the fibrotic process in SSc.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
M. Matucci Cerinic and M. B. Kahaleh
Beauty and the Beast. The nitric oxide paradox in systemic sclerosis
Rheumatology, August 1, 2002; 41(8): 843 - 847.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. E. Girgis, M. K. Gugnani, J. Abrams, and M. D. Mayes
Partitioning of Alveolar and Conducting Airway Nitric Oxide in Scleroderma Lung Disease
Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1587 - 1591.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
Y. Allanore, D. Borderie, P. Hilliquin, A. Hernvann, M. Levacher, H. Lemarechal, O. G. Ekindjian, and A. Kahan
Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells
Rheumatology, October 1, 2001; 40(10): 1089 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. Cavallo, L. Sabadini, L. Rollo, M. Catenaccio, S. Lorenzini, N. Pipitone, R. Marcolongo, and T. Yamamoto
Nitric oxide synthesis in peripheral blood mononuclear and polymorphonuclear cells from patients with systemic sclerosis
Rheumatology, December 1, 1999; 38(12): 1301 - 1304.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.